Literature DB >> 11698629

Initial experience with Song's covered duodenal stent in the treatment of malignant gastroduodenal obstruction.

J E Lopera1, O Alvarez, R Castaño, W Castañeda-Zuñiga.   

Abstract

PURPOSE: Initial experience with use of Song's covered duodenal stent in the treatment of malignant gastroduodenal obstruction is reported.
MATERIALS AND METHODS: Sixteen consecutive patients with malignant gastroduodenal obstruction were treated with peroral placement of Song's covered duodenal stent. The mean age was 58 years (range, 28-90 y). Gastroduodenal obstruction was caused by gastric (n = 8), metastatic (n = 2), gallbladder (n = 3), pancreatic (n = 2), or ampullary (n = 1) cancer. The disease was considered inoperable in all patients. With use of a flexible 20-F introducing system, seven fully covered, three uncovered, and 10 partially covered duodenal stents were placed under fluoroscopic guidance.
RESULTS: The technical success rate was 94% (15 of 16) with no major complications. Symptoms of gastroduodenal obstruction improved in 14 patients. Stent migration was observed in three of seven fully covered stents. Patients with migrated stents required endoscopic stent removal and placement of uncovered duodenal stents. Tumor ingrowth was observed in two thirds of uncovered stents. In the 10 procedures with partially covered duodenal stents, no migration or tumor ingrowth was observed. All patients died 1-48 weeks (mean, 12 weeks) after stent placement.
CONCLUSION: Peroral placement of Song's covered duodenal stent is a feasible and effective method of palliation in the majority of patients with malignant gastroduodenal obstruction. Migration of fully covered stents and tumor ingrowth of uncovered stents are important limitations that can be overcome with the use of a partially covered duodenal stent.

Entities:  

Mesh:

Year:  2001        PMID: 11698629     DOI: 10.1016/s1051-0443(07)61555-3

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  9 in total

1.  Obstructive jaundice after bilioenteric anastomosis: transhepatic and direct percutaneous enteral stent insertion for afferent loop occlusion.

Authors:  Hans-Ulrich Laasch
Journal:  Gut Liver       Date:  2010-09-10       Impact factor: 4.519

Review 2.  Interventional upper endoscopy: the adult perspective.

Authors:  Tonya Kaltenbach; Seth Crockett; George Triadafilopoulos
Journal:  Curr Gastroenterol Rep       Date:  2006-12

3.  Self-expandable metallic stent placement for malignant obstruction in patients with locally recurrent gastric cancer.

Authors:  Jaihwan Kim; Il Ju Choi; Chan Gyoo Kim; Jong Yeul Lee; Soo-Jeong Cho; Sook Ryun Park; Jun Ho Lee; Keun Won Ryu; Young-Woo Kim; Young-Iee Park
Journal:  Surg Endosc       Date:  2010-10-26       Impact factor: 4.584

4.  Malignant gastric outlet obstructions: treatment with self-expandable metallic stents.

Authors:  Jin Hyoung Kim; Ho-Young Song; Ji Hoon Shin
Journal:  Gut Liver       Date:  2010-09-10       Impact factor: 4.519

5.  Gastroduodenal stenting.

Authors:  Derrick F Martin; Hans-Ulrich Laasch
Journal:  Semin Intervent Radiol       Date:  2004-09       Impact factor: 1.513

6.  Treatment of gastric outlet and duodenal obstructions with uncovered expandable metal stents.

Authors:  Qiang Huang; Ding-Ke Dai; Xiao-Jun Qian; Ren-You Zhai
Journal:  World J Gastroenterol       Date:  2007-10-28       Impact factor: 5.742

7.  Endoscopic stenting: where are we now and where can we go?

Authors:  Mark-Terence McLoughlin; Michael-Francis Byrne
Journal:  World J Gastroenterol       Date:  2008-06-28       Impact factor: 5.742

Review 8.  Treatment of malignant gastric outlet obstruction with stents: an evaluation of the reported variables for clinical outcome.

Authors:  Lene Larssen; Asle W Medhus; Truls Hauge
Journal:  BMC Gastroenterol       Date:  2009-06-17       Impact factor: 3.067

Review 9.  Stent versus gastrojejunostomy for the palliation of gastric outlet obstruction: a systematic review.

Authors:  Suzanne M Jeurnink; Casper H J van Eijck; Ewout W Steyerberg; Ernst J Kuipers; Peter D Siersema
Journal:  BMC Gastroenterol       Date:  2007-06-08       Impact factor: 3.067

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.